CIA
CRMD icon

Concurrent Investment Advisors’s CorMedix CRMD Stock Holding History

Concurrent Investment Advisors’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$341K Sell
43,400
-4,500
-9% -$35.5K ﹤0.01% 1623
2026
Q1 		$325K Buy
47,900
+11,550
+32% +$85.4K ﹤0.01% 1445
2025
Q4 		$423K Buy
+36,350
New +$402K ﹤0.01% 1223

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Concurrent Investment Advisors's CRMD Position: Q2 2026 in Review

Concurrent Investment Advisors reduced its CorMedix (CRMD) stake by 9.4% in Q2 2026, selling an estimated $35.5K and leaving 43,400 shares worth $341K. The position accounts for ﹤0.01% of the portfolio, ranked #1623.

Concurrent Investment Advisors first reported a position in CRMD in Q4 2025 and has held it in 3 quarters since. The position peaked at $423K in Q4 2025. 194 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • Concurrent Investment Advisors held 43,400 shares of CorMedix worth $341K as of Q2 2026.
  • Concurrent Investment Advisors sold 4,500 CorMedix shares in Q2 2026, an estimated $35.5K.
  • CorMedix made up ﹤0.01% of Concurrent Investment Advisors's portfolio in Q2 2026, its #1623 holding.
  • Concurrent Investment Advisors first reported a position in CorMedix in Q4 2025 and has held it in 3 quarters since.
  • Concurrent Investment Advisors's CorMedix position peaked at $423K in Q4 2025.
  • 194 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Concurrent Investment Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.